Clinical trial
A Phase I Trial of Tamoxifen and 9-Cis-Retinoic Acid in Breast Cancer Patients
NCT00001504 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00001504 |
|---|---|
| Title | A Phase I Trial of Tamoxifen and 9-Cis-Retinoic Acid in Breast Cancer Patients |
| Official title | A Phase I Trial of Tamoxifen and 9-Cis-Retinoic Acid in Breast Cancer Patients |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Breast Cancer, Breast Neoplasm |
| Intervention type | Drug |
| Interventions | 9-cis-Retinoic Acid |
| Enrollment | 18 |
| Start date | May 1, 1996 |
| Completion | Jan 1, 2002 |
| First posted | Nov 4, 1999 |
| Last update posted | Mar 4, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: